Data as of Sep 29, 2026 · Based on 135 AI responses · See how Parse measures this
Caris Life Sciences delivers precision oncology solutions through tissue and blood-based molecular profiling, AI analytics, and clinical decision support to guide cancer diagnosis and treatment using multimodal data. Its Caris Detect product is a multi-cancer early-detection blood test that analyzes the entire genome with AI, powered by a large molecular-dataset (50 billion markers from over 1 million patient cases) to detect cancer signals before symptoms. The company also offers AI-driven tools such as Caris GPSai and Caris FOLFIRSTai, molecular tumor boards, and clinical trial matching to support personalized cancer care.
1%0% before. Up 1 point.
of AI answers about Caris Detect and its rivals. Week of Sep 21
“Caris Detect (by Caris Life Sciences) : Launched recently, this newer entrant leverages ultra-deep whole genome and transcriptome sequencing”
“Caris Detect (by Caris Life Sciences) : Launched in mid-2026, Caris Detect is a comprehensive MCED test”
AI mentioned Caris Detect in 1% of answers about Caris Detect and its rivals in the week of Sep 21.
Caris Detect is a product of Caris Life Sciences.
Excerpts where Caris Detect appeared in the AI's answer
Caris Detect (by Caris Life Sciences) : Launched recently, this newer entrant leverages ultra-deep whole genome and transcriptome sequencing
Caris Detect (by Caris Life Sciences) : Launched in mid-2026, Caris Detect is a comprehensive MCED test
